Foulkes J G, Jefferson L S
Diabetes. 1984 Jun;33(6):576-9. doi: 10.2337/diab.33.6.576.
Protein phosphatase activities have recently been classified into two major groups of enzymes termed type 1 and type 2. In the present study, this classification scheme has been used to explore the types of protein phosphatase activities found in rat heart, liver, and skeletal muscle, and to determine the type of protein phosphatase activity affected by diabetes. Protein phosphatase activities have been measured under conditions designed to minimize the influence of effectors of these enzymes, and a thermostable protein phosphatase inhibitor, termed inhibitor-2, has been used as a probe to specifically inhibit type 1 protein phosphatase. The specific activity of protein phosphatase-1 in extracts of heart, liver, and skeletal muscle from control rats ranged between 0.34 and 0.44 U/mg protein. The specific activity of a type 2 enzyme, termed protein phosphatase-2A, was approximately the same as protein phosphatase-1 in the case of skeletal muscle extracts, but was about 50% higher than type 1 in extracts from liver and heart. The only significant effect of diabetes was on hepatic protein phosphatase-1 in which a 50% decrease in specific activity was noted. Therefore, the effect of diabetes appeared to be confined to protein phosphatase-1 and this effect was only seen in liver.
蛋白磷酸酶活性最近被分为1型和2型这两大类酶。在本研究中,这种分类方案已被用于探究大鼠心脏、肝脏和骨骼肌中发现的蛋白磷酸酶活性类型,并确定受糖尿病影响的蛋白磷酸酶活性类型。蛋白磷酸酶活性是在旨在尽量减少这些酶的效应物影响的条件下测量的,一种称为抑制剂-2的热稳定蛋白磷酸酶抑制剂已被用作特异性抑制1型蛋白磷酸酶的探针。对照大鼠心脏、肝脏和骨骼肌提取物中蛋白磷酸酶-1的比活性在0.34至0.44 U/mg蛋白之间。在骨骼肌提取物中,一种称为蛋白磷酸酶-2A的2型酶的比活性与蛋白磷酸酶-1大致相同,但在肝脏和心脏提取物中比1型酶高约50%。糖尿病的唯一显著影响是对肝脏中的蛋白磷酸酶-1,其比活性下降了50%。因此,糖尿病的影响似乎仅限于蛋白磷酸酶-1,且这种影响仅在肝脏中可见。